Enocitabine
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | IV |
| ATC code | none |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
55726-47-1 |
| PubChem (CID) | 71734 |
| ChemSpider |
64778 |
| UNII |
9YVR68W306 |
| KEGG |
D01633 |
| ChEMBL |
CHEMBL2106589 |
| Chemical and physical data | |
| Formula | C31H55N3O6 |
| Molar mass | 565.78 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.
Sunrabin contains the emulsifier HCO-60, which can cause allergic reactions.[1]
References
- (Japanese) Sunrabin
This article is issued from Wikipedia - version of the 9/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
